Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 25, 2019
Emergex Vaccines has successfully secured a state-of-the-art-research and development (R&D) facility at Milton Park, Oxfordshire.
read more
Monday, February 25, 2019
WuXi Biologics announced that the EMA has completed the PAI of the company's cGMP Drug Substance and Drug Product manufacturing facilities for the production of Trogarzo with no critical findings.
read more
Monday, February 25, 2019
Oakrum Pharma has entered into an agreement with Aucta to develop and manufacture four prescription generic pharmaceutical products that are intended to be commercialized in the U.S. under the Oakrum label.
read more
Monday, February 25, 2019
Codexis announces the appointment of Laurie Heilmann to Senior Vice President of Business Development and Marketing.
read more
Monday, February 25, 2019
Nemus Bioscience has signed an agreement with Pharmaceuticals International Inc. (Pii), a CDMO to develop a sterile eye drop dosage formulation of NB1111 for human dosing.
read more
Monday, February 25, 2019
Roche and Spark Therapeutics announced that they have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction.
read more
Tuesday, February 26, 2019
Wilmington PharmaTech is planning to hire up to 139 new employees and invest $18 million in a new state-of-the-science research and manufacturing facility.
read more
Tuesday, February 26, 2019
CRF Bracket closed the fourth quarter calendar year showing more than a 20% increase in new clinical trial business.
read more
Tuesday, February 26, 2019
Lonza announced Richard Ridinger, CEO, has decided to retire from the company after seven years.
read more
Wednesday, February 27, 2019
Synergy confirmed that the previously announced agreement with Bausch Health Companies has been designated as the highest and best offer for Synergy's assets, including all rights to TRULANCE®.
read more
Wednesday, February 27, 2019
Chiesi USA will occupy the top two floors of Regency Woods II, a six-story development by The Spectrum Companies located off U.S. 64 near Symphony Lake in North Carolina.
read more
Wednesday, February 27, 2019
PredictImmune confirmed its latest patent grant in the US. The US patent is part of PredictImmune’s third family of IP relating to methods for predicting autoimmune disease risk.
read more
Wednesday, February 27, 2019
PAREXEL announced several new appointments that will enhance the company’s oncology expertise as oncology trials grow in number and complexity.
read more
Wednesday, February 27, 2019
Notable has expanded its management team with Hiroomi Tada as Chief Medical Officer and Lloyd Mackenzie as Chief Development Officer.
read more
Thursday, February 28, 2019
WuXi Biologics congratulates its strategic partner Amicus Therapeutics on receiving FDA Breakthrough Therapy Designation for AT-GAA (ATB200/AT2221).
read more